BrainStorm enrolls first patients in advanced ALS stem cell trial – Business Insider
WeeklyHub |
BrainStorm enrolls first patients in advanced ALS stem cell trial
Business Insider TEL AVIV, Oct 16 (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at Massachusetts General Hospital and UC Irvine Medical Center in … BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS Brainstorm Cell Therapeutics (NASDAQ:BCLI) Getting Somewhat Favorable Press Coverage, Report Shows Analysts See $-0.10 EPS for Brainstorm Cell Therapeutics Inc (BCLI) |
